Kahr Bio Australia Pty Ltd
1 clinical trials · Sponsor
◉ Watch Kahr Bio Australia Pty Ltd
| Record | Firm | Date |
|---|---|---|
| A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer. (NCT07235293) | Kahr Bio Australia Pty Ltd | 2026-01-16 |
Track Kahr Bio Australia Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.